Minimum 10-Year Results of Single- Versus Double-Bundle Posterior Cruciate Ligament Reconstruction: Clinical, Radiologic, and Survivorship Outcomes

医学 生存曲线 骨关节炎 后交叉韧带 射线照相术 外科 队列 回顾性队列研究 前交叉韧带 内科学 癌症 病理 替代医学
作者
Kyoung Ho Yoon,Eung Ju Kim,Yoo Beom Kwon,Sang‐Gyun Kim
出处
期刊:American Journal of Sports Medicine [SAGE Publishing]
卷期号:47 (4): 822-827 被引量:48
标识
DOI:10.1177/0363546518825257
摘要

BACKGROUND: Biomechanical studies have shown that double-bundle (DB) posterior cruciate ligament reconstruction (PCLR) is better than single-bundle (SB) PCLR in restoring normal biomechanical function and stability. However, most clinical studies report no differences between the technical methods, and there is yet no long-term clinical comparative study. HYPOTHESIS: DB PCLR would show superior results and survivorship outcomes to those of SB PCLR in long-term follow-up. STUDY DESIGN: Cohort study; Level of evidence, 3. METHODS: The authors retrospectively evaluated 64 patients who underwent primary PCLR between 2000 and 2008 and were followed up for a minimum of 10 years: 28 patients underwent SB PCLR (mean ± SD: age, 29.1 ± 12.2 years), and 36 underwent DB PCLR (age, 27.0 ± 9.2 years). Clinical scores (International Knee Documentation Committee subjective score, Lysholm score, Tegner activity score), side-to-side difference in stress radiographs, osteoarthritis progression, and survival rate were compared between the SB and DB groups at the last follow-up. RESULTS: At the final follow-up, all clinical scores showed no significant differences between the SB and DB groups. The mean side-to-side difference in stress radiographs (SB, 5.3 ± 3.5 mm; DB, 5.0 ± 3.8 mm; P = .828) and osteoarthritis progression (SB, 14.3%; DB, 13.9%; P = .964) were not different between the groups. The 15-year survival rate was 82.1% for SB PCLR and 83.7% for DB PCLR. CONCLUSION: Both the SB and DB techniques for PCLR showed satisfactory long-term clinical results and survivorship outcomes. There were no significant differences between SB and DB PCLR in clinical, radiologic, and survivorship outcomes at a minimum follow-up of 10 years. CLINICAL RELEVANCE: DB PCLR did not show superior clinical results to those of SB PCLR in the long-term follow-up. These results should be considered in the surgical planning for PCLR.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
molihuakai的应助被酷酷画笔采纳,获得30
刚刚
科研通AI6.4的应助被yimo采纳,获得10
刚刚
1秒前
HM发布了新的文献求助10
1秒前
美满的擎宇完成签到 ,获得积分10
2秒前
大模型的应助被怡然千萍采纳,获得10
2秒前
adasdad完成签到 ,获得积分10
3秒前
悦耳邑完成签到,获得积分10
3秒前
张晓芮完成签到 ,获得积分10
3秒前
木村发布了新的文献求助10
4秒前
Ava的应助被木子采纳,获得10
5秒前
6秒前
7秒前
7秒前
8秒前
贝加尔湖畔完成签到,获得积分10
8秒前
lin完成签到,获得积分20
9秒前
Daric发布了新的文献求助10
10秒前
机灵的yy完成签到,获得积分10
11秒前
李帅祖发布了新的文献求助10
11秒前
木村完成签到,获得积分20
13秒前
酷酷画笔发布了新的文献求助30
13秒前
无情硬币发布了新的文献求助10
13秒前
14秒前
科研通AI6.4的应助被gulugulugulug采纳,获得10
14秒前
16秒前
猖狂战神发布了新的文献求助10
16秒前
hhhh完成签到,获得积分10
16秒前
16秒前
17秒前
机智若雁发布了新的文献求助30
18秒前
18秒前
HM完成签到,获得积分10
19秒前
20秒前
高兴翠柏完成签到,获得积分10
21秒前
ssssen完成签到,获得积分20
21秒前
22秒前
22秒前
小蘑菇的应助被fanger采纳,获得10
22秒前
23秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Spec 401: Standards for Jet Fuel Facility and Equipment Commissioning and Flushing at Airports, 2026.1 (Original Issue) 1000
Spec 103: Standard for Jet Fuel Quality Control at Airports, Revision 2026.1 1000
Les Mots du discours 600
The Future of Digital Well-Being 600
5th World Conference on Detergents: Reinventing the Industry : Opportunities and Challenges 500
Erzählte Gnade 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8100548
求助须知:如何正确求助?哪些是违规求助? 9510798
关于积分的说明 21476828
捐赠科研通 7676056
什么是DOI,文献DOI怎么找? 3408158
关于科研通互助平台的介绍 2535958
邀请新用户注册赠送积分活动 2447907